FDAnews
www.fdanews.com/articles/198630-fda-authorizes-cytosorbents-blood-purification-technology-for-emergency-use

FDA Authorizes CytoSorbents’ Blood Purification Technology for Emergency Use

August 20, 2020

CytoSorbents has received an Emergency Use Authorization (EUA) from the FDA for its CytoSorb blood purification technology, allowing its use in critically ill COVID-19 patients.

The EUA makes CytoSorb available for use in COVID-19 patients 18 years of age and older who are in the intensive care unit for respiratory failure. The purification technology reduces cytokine storm and inflammatory responses.

The cytokine adsorber works with the most commonly used blood purification machines and pumps.

View today's stories